摘要
目的:探讨血管栓塞术治疗脑动脉瘤患者的临床效果及对预后的影响。方法:选取2017年11月-2018年11月本院收治的脑动脉瘤患者90例。按随机数字表法分为研究组和对照组,各45例。对照组给予开颅夹闭术治疗,研究组给予血管栓塞术治疗。比较两组治疗效果、并发症发生情况、免疫功能指标及术后1年预后情况。结果:术后7 d,研究组CD3^(+)、CD4^(+)及CD4^(+)/CD8^(+)均高于对照组,且CD8^(+)低于对照组(P<0.05);研究组治疗总有效率高于对照组(P<0.05);研究组并发症发生率低于对照组(P<0.05);研究组术后1年预后情况优于对照组(P<0.05)。结论:血管栓塞术治疗脑动脉瘤患者可提高治疗总有效率,减少并发症的发生,促使患者免疫功能改善,预后良好,可推广使用。
Objective:To investigate the clinical effect of embolization in the treatment of cerebral aneurysm and its effect on prognosis.Method:A total of 90 patients with cerebral aneurysm admitted to our hospital from November 2017 to November 2018 were selected.According to random number table method,they were divided into study group and control group,with 45 cases in each group.The control group was treated with craniotomy and clipping,while the study group was treated with embolization.The therapeutic efficacy,complications,immune function indexes and postoperative 1 year prognosis were compared between the two groups.Result:7 d after surgery,CD3^(+),CD4^(+) and CD4^(+)/CD8^(+) in the study group were higher than those in the control group,and CD8^(+) was lower than that in the control group (P<0.05).The total effective rate of the study group was higher than that of the control group (P<0.05).The complication rate of the study group was lower than that of the control group (P<0.05).The postoperative 1 year prognosis of the study group was better than that of the control group (P<0.05).Conclusion:Embolization in the treatment of cerebral aneurysm patients can improve the total effective rate,reduce the incidence of complications,improve the immune function of patients,and have a good prognosis,so it can be popularized.
作者
任广军
REN Guangjun(Shuangyashan Agricultural Reclamation Hongxinglong Administration Central Hospital,Shuangyashan 155811,China)
出处
《中国医学创新》
CAS
2021年第5期5-8,共4页
Medical Innovation of China
关键词
脑动脉瘤
血管栓塞术
预后
Cerebral aneurysm
Embolization
Prognosis